Atom Investors »

Ultragenyx Pharmaceutical shares owned by Atom Investors

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 94k 20.95

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Bio-techne Corporation (TECH)
Equinix (EQIX)
Broadcom (AVGO)
Scotts Miracle-gro Cl A (SMG)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
LKQ Corporation (LKQ)
Carlisle Companies (CSL)
Dianthus Therapeutics (DNTH)
Ameren Corporation (AEE)
Reliance Steel & Aluminum (RS)
Wright Express (WEX)
Celcuity (CELC)
H&R Block (HRB)

View all positions for Atom Investors

Top funds holding Ultragenyx Pharmaceutical

BlackRock
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Vanguard Capital Management
Rtw Investments
Sofinnova Ventures
Sands Capital Management
Wellington Management Company
Bellevue Group
Citadel Advisors
Two Sigma Investments
Frontier Capital Management
Geode Capital Management
Millennium Management

View all funds holding Ultragenyx Pharmaceutical